- Presentations
- 3
- Markets
- 1
Somatuline Depot is a brand of Lanreotide marketed by Ipsen Biopharmaceuticals, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Lanreotide
- Brand owner
- Ipsen Biopharmaceuticals
- Registered in
- United States
- Strengths and forms
- 120 mg/0.5 mL injection, 60 mg/0.2 mL injection, 90 mg/0.3 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Somatuline Depot 120 mg/0.5 mL injectionSubcutaneous Cold chain | Ipsen Biopharmaceuticals | US FDA | Available on request |
| Somatuline Depot 60 mg/0.2 mL injectionSubcutaneous Cold chain | Ipsen Biopharmaceuticals | US FDA | Available on request |
| Somatuline Depot 90 mg/0.3 mL injectionSubcutaneous Cold chain | Ipsen Biopharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Somatuline Depot
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.